ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-1033
Full Text
Open PDFAbstract
Available in full text
Date
March 14, 2014
Authors
Publisher
American Association for Cancer Research (AACR)